← Back to Search

Contact Ultrasonic Debridement Device

Contact Ultrasonic Debridement Device for Bedsores

N/A
Waitlist Available
Led By Oscar M Alvarez, PhD
Research Sponsored by Calvary Hospital, Bronx, NY
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group

Summary

A single center, randomized, parallel, clinical outcome trial to compare the rate of healing in chronic wounds debrided with either high energy ultrasonic debridement (with cavitation) or standard of care sharp debridement.

Eligible Conditions
  • Bedsores

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Active Control
Group I: Contact Ultrasonic Debridement DeviceActive Control1 Intervention
Group II: Standard Sharp DebridementActive Control1 Intervention

Find a Location

Who is running the clinical trial?

Calvary Hospital, Bronx, NYLead Sponsor
12 Previous Clinical Trials
1,448 Total Patients Enrolled
Martin E Wendelken, DPM, RNStudy DirectorPhysician, Wound Care Center, Calvary Hospital
Oscar M Alvarez, PhDPrincipal InvestigatorDirector, Wound care Center, Calvary Hospital
5 Previous Clinical Trials
199 Total Patients Enrolled
~4 spots leftby Nov 2025